← Leaderboards
James Burton Whitney
Beth Israel Deaconess Medical Center
$8,899,901
Attributed
$8,899,901
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,445,344 · 7
By mechanism
P01$10,505,619 · 3
R01$3,528,681 · 1
R56$2,411,044 · 3
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Alex Toker$16,651,718
- Mark A Herman$6,685,137
- Vassiliki A Boussiotis$19,288,605
- Thomas F Deuel$8,069,433
- Elliot Chaikof$40,570,541
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsViralLocationAntiretroviral TherapyViremiaHiv InfectionsRegimenVirusPlasmaViral ReservoirFosteringMemory Cd4 T LymphocyteImmunologicsNonhuman PrimateEarly TreatmentAnatomyRefractoryMacaca MulattaTissuesPharmaceutical PreparationsAnti-Retroviral AgentsInfectionImmune ResponseLaboratories
Grant awards (24)
Understanding formation and dynamics of the SIV reservoir.$824,331
R56 · FY2025 · AI · contact PI
Viral dynamics of rebound and control following early treatment of HIV/SIV$1,502,071
P01 · FY2021 · AI · contact PI
Project 3: Viral dynamics of Remission or Rebound Following Early Treatment of SIV$345,976
P01 · FY2021 · AI · contact PI
Administrative Core$206,453
P01 · FY2021 · AI · contact PI
Viral dynamics of rebound and control following early treatment of HIV/SIV$1,516,899
P01 · FY2020 · AI · contact PI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs$479,653
R01 · FY2020 · AI · contact PI
Administrative Core$397,126
P01 · FY2020 · AI · contact PI
Project 3: Viral dynamics of Remission or Rebound Following Early Treatment of SIV$316,035
P01 · FY2020 · AI · contact PI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs$114,275
R01 · FY2020 · AI · contact PI
Viral dynamics of rebound and control following early treatment of HIV/SIV$1,515,070
P01 · FY2019 · AI · contact PI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs$579,143
R01 · FY2019 · AI · contact PI
Project 3: Viral dynamics of Remission or Rebound Following Early Treatment of SIV$323,153
P01 · FY2019 · AI · contact PI
Administrative Core$238,341
P01 · FY2019 · AI · contact PI
Viral dynamics of rebound and control following early treatment of HIV/SIV$1,515,570
P01 · FY2018 · AI · contact PI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs$583,625
R01 · FY2018 · AI · contact PI
Project 3: Viral dynamics of Remission or Rebound Following Early Treatment of SIV$322,289
P01 · FY2018 · AI · contact PI
Administrative Core$275,345
P01 · FY2018 · AI · contact PI
Viral dynamics of rebound and control following early treatment of HIV/SIV$1,495,833
P01 · FY2017 · AI · contact PI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs$1,186,106
R01 · FY2017 · AI · contact PI
Administrative Core$269,460
P01 · FY2017 · AI · contact PI
Project 3: Viral dynamics of Remission or Rebound Following Early Treatment of SIV$265,998
P01 · FY2017 · AI · contact PI
TLR Therapy to Eradicate the SIV Reservoir$737,637
R56 · FY2016 · AI · contact PI
TLR Immunotherapy to Eradicate Anatomic SIV Reservoirs$585,879
R01 · FY2016 · AI · contact PI
Mechanisms of SIV persistence$849,076
R56 · FY2011 · AI · contact PI